KBIO

KALOBIOS PHARMACEUTICALS INCCIK 1293310 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for KBIO PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for KBIO

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Lam Morgan	Chief Scientific Officer	2	$0	$0	2017-02-21
Tousley David L.	Interim CFO	1	$0	$0	2017-02-21
Friedberg Ezra M	Director	1	$0	$0	2016-09-13
Durrant Cameron	Chief Executive Officer	1	$0	$0	2016-09-13
Chappell Dale	Director, 10% Owner	1	$0	$0	2016-09-13
BARLIANT RONALD	Director	1	$0	$0	2016-09-13
MORRIS TIMOTHY E	Director	1	$0	$0	2016-09-13
Shkreli Martin	Chief Executive Officer	9	$2.81M	$6.89M	2016-08-26
Fernandez Thomas Edward	Director	1	$200.0K	$0	2015-12-16
Harrison Michael Wayne	Director	1	$50.0K	$0	2015-12-16
BIESTEK MAREK	Other	4	$710.3K	$0	2015-12-16
Moradi David	Director, 10% Owner	6	$1.04M	$0	2015-12-16
Anthion Partners II LLC	10% Owner	12	$2.03M	$0	2015-11-17
CROSS HERB	Chief Financial Officer	14	$0	$0	2015-11-09
MARTELL RON	Executive Chairman	8	$0	$0	2015-10-28
Smaldone Alsup Laurie	Director	3	$0	$0	2015-07-10
BAFFI ROBERT	Director	2	$0	$0	2015-07-10
GILBERT DENISE	Director	3	$0	$0	2015-07-10
WITHY RAYMOND M	Director	3	$0	$0	2015-07-10
LOVE TED W	Director	3	$0	$0	2015-07-10
LYONS GARY A	Director	3	$0	$0	2015-07-10
Yarranton Geoffrey Thomas	Chief Scientific Officer	3	$0	$0	2015-02-16
Joseph Donald	Chief Legal Officer	3	$0	$0	2015-02-16
LAWLIS V BRYAN	Director	2	$0	$0	2014-06-18
Pritchard David	Chief Executive Officer	2	$0	$0	2014-01-21
Molfino Nestor	Chief Medical Officer	2	$0	$0	2014-01-19
HENNER DENNIS	Director, 10% Owner	7	$0	$0	2013-05-01
Smith Brigitte	Director	9	$200.0K	$0	2013-04-30
Cooper Jeffrey H	Chief Financial Officer	1	$0	$0	2013-04-30
HEALY JAMES	Director	37	$0	$0	2013-04-30
SINGAPORE BIO INNOVATIONS PTE LTD	10% Owner	5	$0	$0	2013-02-05
Lehman Brothers Holdings Inc.	Other	2	$0	$0	2013-02-05
Mitsubishi UFJ Capital II, Limited Partnership	10% Owner	2	$0	$0	2013-02-05
5AM Partners LLC	10% Owner	5	$0	$0	2013-02-05
GBS Venture Partners Pty, Ltd	10% Owner	4	$0	$0	2013-02-05
Alloy Investors 2000, L.P.	10% Owner	7	$0	$0	2013-02-05
Azan Alain	10% Owner	36	$0	$0	2013-02-05
MPM BIOVENTURES III GP L.P.	10% Owner	6	$0	$0	2013-02-05
MPM BIOVENTURES III GMBH & CO. Beteiligungs KG	10% Owner	6	$0	$0	2013-02-05
SIMON NICHOLAS J III	10% Owner	6	$0	$0	2013-02-05
Sanofi	Other	2	$700.0K	$0	2013-02-05
DEVELOPMENT BANK OF JAPAN INC.	10% Owner	2	$0	$0	2013-02-05
BAXTER INTERNATIONAL INC	10% Owner	2	$0	$0	2013-02-05
GBS Bioventures II A/C	10% Owner	1	$200.0K	$0	2013-01-31
5AM VENTURES LLC	10% Owner	1	$500.0K	$0	2013-01-31
SOFINNOVA VENTURE AFFILIATES V LP	10% Owner	3	$3.00M	$0	2013-01-31

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Lam Morgan	Chief Scientific Officer	A Award deriv	2017-02-21	2017-02-22	100,000	—	$0	100,000	SEC↗
Tousley David L.	Interim CFO	A Award deriv	2017-02-21	2017-02-22	100,000	—	$0	100,000	SEC↗
Chappell Dale	Director, 10% Owner	A Award deriv	2016-09-13	2016-09-15	100,000	—	$0	100,000	SEC↗
Lam Morgan	Chief Scientific Officer	A Award deriv	2016-09-13	2016-09-15	100,000	—	$0	100,000	SEC↗
Friedberg Ezra M	Director	A Award deriv	2016-09-13	2016-09-15	100,000	—	$0	100,000	SEC↗
Durrant Cameron	Chief Executive Officer	A Award deriv	2016-09-13	2016-09-15	1,043,022	—	$0	1,043,022	SEC↗
BARLIANT RONALD	Director	A Award deriv	2016-09-13	2016-09-15	100,000	—	$0	100,000	SEC↗
MORRIS TIMOTHY E	Director	A Award deriv	2016-09-13	2016-09-15	100,000	—	$0	100,000	SEC↗
Shkreli Martin	10% Owner	S Sale	2016-08-26	2016-08-29	309,723	$3.10	$960.1K	0	SEC↗
Shkreli Martin	10% Owner	S Sale	2016-08-25	2016-08-29	1,913,206	$3.10	$5.93M	309,723	SEC↗
Moradi David	Director, 10% Owner	P Buy	2015-12-16	2015-12-17	3,410	$29.32	$100.0K	378,210	SEC↗
Moradi David	Director, 10% Owner	P Buy	2015-12-16	2015-12-17	3,410	$29.32	$100.0K	378,210	SEC↗
Harrison Michael Wayne	Director	P Buy	2015-12-16	2015-12-18	1,705	$29.32	$50.0K	1,705	SEC↗
BIESTEK MAREK	Director	P Buy	2015-12-16	2015-12-18	10,000	$29.32	$293.2K	250,000	SEC↗
Fernandez Thomas Edward	Director	P Buy	2015-12-16	2015-12-18	6,821	$29.32	$200.0K	6,821	SEC↗
Moradi David	Director, 10% Owner	P Buy	2015-12-16	2015-12-18	3,410	$29.32	$100.0K	178,210	SEC↗
Moradi David	Director, 10% Owner	P Buy	2015-12-16	2015-12-18	3,410	$29.32	$100.0K	178,210	SEC↗
Shkreli Martin	Chief Executive Officer	P Buy	2015-11-24	2015-11-24	5,000	$38.15	$190.8K	2,075,200	SEC↗
Shkreli Martin	Chief Executive Officer	P Buy	2015-11-20	2015-11-23	5,000	$18.88	$94.4K	2,070,200	SEC↗
Shkreli Martin	10% Owner	P Buy	2015-11-18	2015-11-19	440,000	$2.02	$888.8K	2,065,200	SEC↗
BIESTEK MAREK	Other	P Buy	2015-11-18	2015-11-19	40,000	$2.04	$81.6K	240,000	SEC↗
Moradi David	10% Owner	P Buy	2015-11-18	2015-11-19	150,000	$2.13	$319.5K	574,800	SEC↗
Moradi David	10% Owner	P Buy	2015-11-18	2015-11-19	150,000	$2.13	$319.5K	574,800	SEC↗
Shkreli Martin	10% Owner	P Buy	2015-11-17	2015-11-18	606,677	$1.93	$1.17M	1,618,200	SEC↗
Shkreli Martin	10% Owner	P Buy	2015-11-17	2015-11-18	7,000	$2.43	$17.0K	1,625,200	SEC↗
Anthion Partners II LLC	10% Owner	P Buy	2015-11-17	2015-11-18	113,800	$1.69	$192.3K	424,800	SEC↗
Anthion Partners II LLC	10% Owner	P Buy	2015-11-17	2015-11-18	113,800	$1.69	$192.3K	424,800	SEC↗
Anthion Partners II LLC	10% Owner	P Buy	2015-11-17	2015-11-18	113,800	$1.69	$192.3K	424,800	SEC↗
Anthion Partners II LLC	10% Owner	P Buy	2015-11-17	2015-11-18	113,800	$1.69	$192.3K	424,800	SEC↗
BIESTEK MAREK	Other	P Buy	2015-11-17	2015-11-19	135,000	$1.83	$247.1K	200,000	SEC↗
Shkreli Martin	10% Owner	P Buy	2015-11-16	2015-11-18	500,169	$0.61	$305.1K	914,254	SEC↗
Shkreli Martin	10% Owner	P Buy	2015-11-16	2015-11-18	97,269	$1.43	$139.1K	1,011,523	SEC↗
Anthion Partners II LLC	10% Owner	P Buy	2015-11-16	2015-11-18	225,963	$1.26	$284.7K	293,900	SEC↗
Anthion Partners II LLC	10% Owner	P Buy	2015-11-16	2015-11-18	225,963	$1.26	$284.7K	293,900	SEC↗
Anthion Partners II LLC	10% Owner	P Buy	2015-11-16	2015-11-18	17,100	$1.76	$30.1K	311,000	SEC↗
Anthion Partners II LLC	10% Owner	P Buy	2015-11-16	2015-11-18	17,100	$1.76	$30.1K	311,000	SEC↗
Anthion Partners II LLC	10% Owner	P Buy	2015-11-16	2015-11-18	225,963	$1.26	$284.7K	293,900	SEC↗
Anthion Partners II LLC	10% Owner	P Buy	2015-11-16	2015-11-18	225,963	$1.26	$284.7K	293,900	SEC↗
Anthion Partners II LLC	10% Owner	P Buy	2015-11-16	2015-11-18	17,100	$1.76	$30.1K	311,000	SEC↗
Anthion Partners II LLC	10% Owner	P Buy	2015-11-16	2015-11-18	17,100	$1.76	$30.1K	311,000	SEC↗
BIESTEK MAREK	Other	P Buy	2015-11-16	2015-11-19	65,000	$1.36	$88.4K	65,000	SEC↗
CROSS HERB	Chief Financial Officer	A Award deriv	2015-11-09	2015-11-10	1,875	—	$0	1,875	SEC↗
MARTELL RON	Executive Chairman	A Award deriv	2015-10-28	2015-10-28	3,125	—	$0	3,125	SEC↗
CROSS HERB	Chief Financial Officer	A Award deriv	2015-10-08	2015-10-08	1,875	—	$0	1,875	SEC↗
MARTELL RON	Executive Chairman	A Award deriv	2015-09-28	2015-09-28	3,125	—	$0	3,125	SEC↗
CROSS HERB	Chief Financial Officer	A Award deriv	2015-09-08	2015-09-22	1,875	—	$0	1,875	SEC↗
MARTELL RON	Executive Chairman	A Award deriv	2015-08-28	2015-09-22	3,125	—	$0	3,125	SEC↗
CROSS HERB	Chief Financial Officer	A Award deriv	2015-08-10	2015-08-11	1,875	—	$0	1,875	SEC↗
MARTELL RON	Executive Chairman	A Award deriv	2015-07-30	2015-07-30	3,125	—	$0	3,125	SEC↗
BAFFI ROBERT	Director	A Award deriv	2015-07-10	2015-07-14	5,000	—	$0	5,000	SEC↗
GILBERT DENISE	Director	A Award deriv	2015-07-10	2015-07-14	5,000	—	$0	5,000	SEC↗
LOVE TED W	Director	A Award deriv	2015-07-10	2015-07-14	5,000	—	$0	5,000	SEC↗
LYONS GARY A	Director	A Award deriv	2015-07-10	2015-07-14	5,000	—	$0	5,000	SEC↗
Smaldone Alsup Laurie	Director	A Award deriv	2015-07-10	2015-07-14	5,000	—	$0	5,000	SEC↗
WITHY RAYMOND M	Director	A Award deriv	2015-07-10	2015-07-14	5,000	—	$0	5,000	SEC↗
CROSS HERB	Chief Financial Officer	A Award deriv	2015-07-07	2015-07-08	15,000	—	$0	15,000	SEC↗
MARTELL RON	Executive Chairman	A Award deriv	2015-06-29	2015-06-30	25,000	—	$0	25,000	SEC↗
CROSS HERB	Chief Financial Officer	A Award deriv	2015-06-08	2015-06-08	15,000	—	$0	15,000	SEC↗
MARTELL RON	Executive Chairman	A Award deriv	2015-05-28	2015-05-28	25,000	—	$0	25,000	SEC↗
CROSS HERB	Chief Financial Officer	A Award deriv	2015-05-07	2015-05-08	15,000	—	$0	15,000	SEC↗
MARTELL RON	Director	A Award deriv	2015-04-22	2015-04-27	30,000	—	$0	30,000	SEC↗
MARTELL RON	Director	A Award deriv	2015-04-22	2015-04-27	30,000	—	$0	30,000	SEC↗
CROSS HERB	Chief Financial Officer	A Award deriv	2015-04-07	2015-04-08	15,000	—	$0	15,000	SEC↗
CROSS HERB	Chief Financial Officer	A Award deriv	2015-03-10	2015-03-10	15,000	—	$0	15,000	SEC↗
Yarranton Geoffrey Thomas	Chief Scientific Officer	A Award deriv	2015-02-16	2015-02-18	300,000	—	$0	300,000	SEC↗
CROSS HERB	Chief Financial Officer	A Award deriv	2015-02-16	2015-02-18	300,000	—	$0	300,000	SEC↗
Joseph Donald	Chief Legal Officer	A Award deriv	2015-02-16	2015-02-18	300,000	—	$0	300,000	SEC↗
CROSS HERB	Chief Financial Officer	A Award deriv	2015-02-06	2015-02-09	15,000	—	$0	15,000	SEC↗
CROSS HERB	Chief Financial Officer	A Award deriv	2015-01-20	2015-01-21	15,000	—	$0	15,000	SEC↗
CROSS HERB	Chief Financial Officer	A Award deriv	2015-01-20	2015-03-13	15,000	—	$0	15,000	SEC↗
BAFFI ROBERT	Director	A Award deriv	2014-11-25	2014-12-01	40,000	—	$0	40,000	SEC↗
Smaldone Alsup Laurie	Director	A Award deriv	2014-06-18	2014-06-20	20,000	—	$0	20,000	SEC↗
LOVE TED W	Director	A Award deriv	2014-06-18	2014-06-20	20,000	—	$0	20,000	SEC↗
LAWLIS V BRYAN	Director	A Award deriv	2014-06-18	2014-06-20	20,000	—	$0	20,000	SEC↗
WITHY RAYMOND M	Director	A Award deriv	2014-06-18	2014-06-20	20,000	—	$0	20,000	SEC↗
LYONS GARY A	Director	A Award deriv	2014-06-18	2014-06-20	20,000	—	$0	20,000	SEC↗
GILBERT DENISE	Director	A Award deriv	2014-06-18	2014-06-20	20,000	—	$0	20,000	SEC↗
Pritchard David	Chief Executive Officer	A Award deriv	2014-01-21	2014-01-22	250,000	—	$0	250,000	SEC↗
Joseph Donald	Chief Legal Officer	A Award deriv	2014-01-19	2014-01-22	40,000	—	$0	40,000	SEC↗
Molfino Nestor	Chief Medical Officer	A Award deriv	2014-01-19	2014-01-22	150,000	—	$0	150,000	SEC↗
Yarranton Geoffrey Thomas	Chief Scientific Officer	A Award deriv	2014-01-19	2014-01-22	75,000	—	$0	75,000	SEC↗
CROSS HERB	Chief Financial Officer	A Award deriv	2013-10-22	2013-10-23	150,000	—	$0	150,000	SEC↗
Smaldone Alsup Laurie	Director	A Award deriv	2013-10-22	2013-10-23	20,000	—	$0	20,000	SEC↗
LAWLIS V BRYAN	Director	A Award deriv	2013-08-29	2013-09-03	20,000	—	$0	20,000	SEC↗
Joseph Donald	Chief Legal Officer	A Award deriv	2013-07-30	2013-08-01	125,000	—	$0	125,000	SEC↗
HENNER DENNIS	Director, 10% Owner	A Award deriv	2013-05-01	2013-05-03	15,000	—	$0	15,000	SEC↗
Yarranton Geoffrey Thomas	Chief Scientific Officer	A Award deriv	2013-04-30	2013-05-02	75,000	—	$0	75,000	SEC↗
Cooper Jeffrey H	Chief Financial Officer	A Award deriv	2013-04-30	2013-05-02	60,000	—	$0	60,000	SEC↗
Molfino Nestor	Chief Medical Officer	A Award deriv	2013-04-30	2013-05-02	90,000	—	$0	90,000	SEC↗
Pritchard David	Chief Executive Officer	A Award deriv	2013-04-30	2013-05-02	150,000	—	$0	150,000	SEC↗
WITHY RAYMOND M	Director	A Award deriv	2013-04-30	2013-05-02	15,000	—	$0	15,000	SEC↗
HEALY JAMES	Director	A Award deriv	2013-04-30	2013-05-02	15,000	—	$0	15,000	SEC↗
LOVE TED W	Director	A Award deriv	2013-04-30	2013-05-02	15,000	—	$0	15,000	SEC↗
LYONS GARY A	Director	A Award deriv	2013-04-30	2013-05-02	15,000	—	$0	15,000	SEC↗
Smith Brigitte	Director	A Award deriv	2013-04-30	2013-05-02	15,000	—	$0	15,000	SEC↗
GILBERT DENISE	Director	A Award deriv	2013-04-30	2013-05-02	15,000	—	$0	15,000	SEC↗
Sanofi	Other	C Conversion deriv	2013-02-05	2013-02-07	431,973	—	$0	0	SEC↗
HENNER DENNIS	Director, 10% Owner	C Conversion deriv	2013-02-05	2013-02-07	1,949,879	—	$0	0	SEC↗
HENNER DENNIS	Director, 10% Owner	C Conversion deriv	2013-02-05	2013-02-07	275,539	—	$0	0	SEC↗
HENNER DENNIS	Director, 10% Owner	C Conversion deriv	2013-02-05	2013-02-07	337,622	—	$0	0	SEC↗
MPM BIOVENTURES III GMBH & CO.	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	1,949,879	—	$0	0	SEC↗
MPM BIOVENTURES III GMBH & CO.	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	337,622	—	$0	0	SEC↗
MPM BIOVENTURES III GMBH & CO.	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	275,539	—	$0	0	SEC↗
MPM BIOVENTURES III GP L.P.	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	1,949,879	—	$0	0	SEC↗
MPM BIOVENTURES III GP L.P.	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	275,539	—	$0	0	SEC↗
MPM BIOVENTURES III GP L.P.	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	337,622	—	$0	0	SEC↗
SIMON NICHOLAS J III	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	1,949,879	—	$0	0	SEC↗
SIMON NICHOLAS J III	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	275,539	—	$0	0	SEC↗
SIMON NICHOLAS J III	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	337,622	—	$0	0	SEC↗
SINGAPORE BIO INNOVATIONS PTE	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	104,387	—	$0	0	SEC↗
SINGAPORE BIO INNOVATIONS PTE	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	51,710	—	$0	0	SEC↗
SINGAPORE BIO INNOVATIONS PTE	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	175,489	—	$0	0	SEC↗
SINGAPORE BIO INNOVATIONS PTE	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	121,149	—	$0	0	SEC↗
Lehman Brothers Holdings Inc.	Other	C Conversion deriv	2013-02-05	2013-02-07	974,940	—	$0	0	SEC↗
HEALY JAMES	Director	C Conversion deriv	2013-02-05	2013-02-07	1,675	—	$0	0	SEC↗
HEALY JAMES	Director	C Conversion deriv	2013-02-05	2013-02-07	9,982	—	$0	0	SEC↗
HEALY JAMES	Director	C Conversion deriv	2013-02-05	2013-02-07	653,356	—	$0	0	SEC↗
HEALY JAMES	Director	C Conversion deriv	2013-02-05	2013-02-07	19,120	—	$0	0	SEC↗
HEALY JAMES	Director	C Conversion deriv	2013-02-05	2013-02-07	5,231	—	$0	0	SEC↗
HEALY JAMES	Director	C Conversion deriv	2013-02-05	2013-02-07	341,236	—	$0	0	SEC↗
HEALY JAMES	Director	C Conversion deriv	2013-02-05	2013-02-07	11,226	—	$0	0	SEC↗
HEALY JAMES	Director	C Conversion deriv	2013-02-05	2013-02-07	2,851	—	$0	0	SEC↗
HEALY JAMES	Director	C Conversion deriv	2013-02-05	2013-02-07	185,996	—	$0	0	SEC↗
HEALY JAMES	Director	C Conversion deriv	2013-02-05	2013-02-07	6,118	—	$0	0	SEC↗
HEALY JAMES	Director	C Conversion deriv	2013-02-05	2013-02-07	1,207	—	$0	0	SEC↗
HEALY JAMES	Director	C Conversion deriv	2013-02-05	2013-02-07	80,731	—	$0	0	SEC↗
HEALY JAMES	Director	C Conversion deriv	2013-02-05	2013-02-07	643	—	$0	0	SEC↗
HEALY JAMES	Director	C Conversion deriv	2013-02-05	2013-02-07	2,565	—	$0	0	SEC↗
HEALY JAMES	Director	C Conversion deriv	2013-02-05	2013-02-07	171,450	—	$0	0	SEC↗
HEALY JAMES	Director	C Conversion deriv	2013-02-05	2013-02-07	1,367	—	$0	0	SEC↗
HEALY JAMES	Director	C Conversion deriv	2013-02-05	2013-02-07	3,143	—	$0	0	SEC↗
HEALY JAMES	Director	C Conversion deriv	2013-02-05	2013-02-07	210,056	—	$0	0	SEC↗
Azan Alain	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	2,565	—	$0	0	SEC↗
Azan Alain	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	3,143	—	$0	0	SEC↗
Azan Alain	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	210,056	—	$0	0	SEC↗
Azan Alain	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	1,675	—	$0	0	SEC↗
Azan Alain	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	9,982	—	$0	0	SEC↗
Azan Alain	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	653,356	—	$0	0	SEC↗
Azan Alain	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	19,120	—	$0	0	SEC↗
Azan Alain	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	5,231	—	$0	0	SEC↗
Azan Alain	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	341,236	—	$0	0	SEC↗
Azan Alain	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	11,226	—	$0	0	SEC↗
Azan Alain	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	2,851	—	$0	0	SEC↗
Azan Alain	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	185,996	—	$0	0	SEC↗
Azan Alain	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	6,118	—	$0	0	SEC↗
Azan Alain	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	1,207	—	$0	0	SEC↗
Azan Alain	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	80,731	—	$0	0	SEC↗
Azan Alain	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	643	—	$0	0	SEC↗
Azan Alain	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	1,367	—	$0	0	SEC↗
Azan Alain	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	171,450	—	$0	0	SEC↗
DEVELOPMENT BANK OF JAPAN INC.	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	431,973	—	$0	0	SEC↗
BAXTER INTERNATIONAL INC	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	842,435	—	$0	0	SEC↗
Mitsubishi UFJ Capital II, Lim	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	345,578	—	$0	0	SEC↗
5AM Partners LLC	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	96,612	—	$0	0	SEC↗
5AM Partners LLC	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	125,185	—	$0	0	SEC↗
5AM Partners LLC	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	175,488	—	$0	0	SEC↗
5AM Partners LLC	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	79,886	—	$0	0	SEC↗
Alloy Investors 2000, L.P.	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	194,965	—	$0	0	SEC↗
Alloy Investors 2000, L.P.	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	224,029	—	$0	0	SEC↗
Alloy Investors 2000, L.P.	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	487,489	—	$0	0	SEC↗
Alloy Investors 2000, L.P.	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	357,693	—	$0	0	SEC↗
Alloy Investors 2000, L.P.	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	181,114	—	$0	0	SEC↗
Alloy Investors 2000, L.P.	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	165,164	—	$0	0	SEC↗
GBS Venture Partners Pty, Ltd	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	215,985	—	$0	0	SEC↗
GBS Venture Partners Pty, Ltd	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	84,406	—	$0	0	SEC↗
GBS Venture Partners Pty, Ltd	10% Owner	C Conversion deriv	2013-02-05	2013-02-07	487,469	—	$0	0	SEC↗
Smith Brigitte	Director	C Conversion deriv	2013-02-05	2013-02-07	170,617	—	$0	0	SEC↗
Smith Brigitte	Director	C Conversion deriv	2013-02-05	2013-02-07	25,322	—	$0	0	SEC↗
Smith Brigitte	Director	C Conversion deriv	2013-02-05	2013-02-07	59,084	—	$0	0	SEC↗
Smith Brigitte	Director	C Conversion deriv	2013-02-05	2013-02-07	146,240	—	$0	0	SEC↗
Smith Brigitte	Director	C Conversion deriv	2013-02-05	2013-02-07	45,368	—	$0	0	SEC↗
Smith Brigitte	Director	C Conversion deriv	2013-02-05	2013-02-07	341,229	—	$0	0	SEC↗
HENNER DENNIS	Director, 10% Owner	C Conversion	2013-02-05	2013-02-07	313,527	—	$0	2,632,928	SEC↗
HENNER DENNIS	Director, 10% Owner	C Conversion	2013-02-05	2013-02-07	1,949,879	—	$0	1,949,879	SEC↗
HENNER DENNIS	Director, 10% Owner	C Conversion	2013-02-05	2013-02-07	369,522	—	$0	2,319,401	SEC↗
MPM BIOVENTURES III GMBH & CO.	10% Owner	C Conversion	2013-02-05	2013-02-07	313,527	—	$0	2,632,928	SEC↗
MPM BIOVENTURES III GMBH & CO.	10% Owner	C Conversion	2013-02-05	2013-02-07	369,522	—	$0	2,319,401	SEC↗
MPM BIOVENTURES III GMBH & CO.	10% Owner	C Conversion	2013-02-05	2013-02-07	1,949,879	—	$0	1,949,879	SEC↗
MPM BIOVENTURES III GP L.P.	10% Owner	C Conversion	2013-02-05	2013-02-07	313,527	—	$0	2,632,928	SEC↗
MPM BIOVENTURES III GP L.P.	10% Owner	C Conversion	2013-02-05	2013-02-07	369,522	—	$0	2,319,401	SEC↗
MPM BIOVENTURES III GP L.P.	10% Owner	C Conversion	2013-02-05	2013-02-07	1,949,879	—	$0	1,949,879	SEC↗
SIMON NICHOLAS J III	10% Owner	C Conversion	2013-02-05	2013-02-07	1,949,879	—	$0	1,949,879	SEC↗
SIMON NICHOLAS J III	10% Owner	C Conversion	2013-02-05	2013-02-07	313,527	—	$0	2,632,928	SEC↗
SIMON NICHOLAS J III	10% Owner	C Conversion	2013-02-05	2013-02-07	369,522	—	$0	2,319,401	SEC↗
SINGAPORE BIO INNOVATIONS PTE	10% Owner	C Conversion	2013-02-05	2013-02-07	472,013	—	$0	474,018	SEC↗
Lehman Brothers Holdings Inc.	Other	C Conversion	2013-02-05	2013-02-07	1,067,059	—	$0	1,067,059	SEC↗
HEALY JAMES	Director	C Conversion	2013-02-05	2013-02-07	5,231	—	$0	13,683	SEC↗
HEALY JAMES	Director	C Conversion	2013-02-05	2013-02-07	6,118	—	$0	9,291	SEC↗
HEALY JAMES	Director	C Conversion	2013-02-05	2013-02-07	185,996	—	$0	560,201	SEC↗
HEALY JAMES	Director	C Conversion	2013-02-05	2013-02-07	2,851	—	$0	8,452	SEC↗
HEALY JAMES	Director	C Conversion	2013-02-05	2013-02-07	11,226	—	$0	20,517	SEC↗
HEALY JAMES	Director	C Conversion	2013-02-05	2013-02-07	341,236	—	$0	901,437	SEC↗
HEALY JAMES	Director	C Conversion	2013-02-05	2013-02-07	19,120	—	$0	39,637	SEC↗
HEALY JAMES	Director	C Conversion	2013-02-05	2013-02-07	653,356	—	$0	1,554,793	SEC↗
HEALY JAMES	Director	C Conversion	2013-02-05	2013-02-07	9,982	—	$0	23,665	SEC↗
HEALY JAMES	Director	C Conversion	2013-02-05	2013-02-07	1,392	—	$0	31,415	SEC↗
HEALY JAMES	Director	C Conversion	2013-02-05	2013-02-07	93,129	—	$0	2,072,914	SEC↗
HEALY JAMES	Director	C Conversion	2013-02-05	2013-02-07	742	—	$0	43,767	SEC↗
HEALY JAMES	Director	C Conversion	2013-02-05	2013-02-07	2,918	—	$0	30,023	SEC↗
HEALY JAMES	Director	C Conversion	2013-02-05	2013-02-07	195,088	—	$0	1,979,785	SEC↗
HEALY JAMES	Director	C Conversion	2013-02-05	2013-02-07	1,555	—	$0	43,025	SEC↗
HEALY JAMES	Director	C Conversion	2013-02-05	2013-02-07	3,440	—	$0	27,105	SEC↗
HEALY JAMES	Director	C Conversion	2013-02-05	2013-02-07	229,904	—	$0	1,784,697	SEC↗
HEALY JAMES	Director	C Conversion	2013-02-05	2013-02-07	1,833	—	$0	41,470	SEC↗
Azan Alain	10% Owner	C Conversion	2013-02-05	2013-02-07	11,226	—	$0	20,517	SEC↗
Azan Alain	10% Owner	C Conversion	2013-02-05	2013-02-07	341,236	—	$0	901,437	SEC↗
Azan Alain	10% Owner	C Conversion	2013-02-05	2013-02-07	5,231	—	$0	13,683	SEC↗
Azan Alain	10% Owner	C Conversion	2013-02-05	2013-02-07	19,120	—	$0	39,637	SEC↗
Azan Alain	10% Owner	C Conversion	2013-02-05	2013-02-07	653,356	—	$0	1,554,793	SEC↗
Azan Alain	10% Owner	C Conversion	2013-02-05	2013-02-07	1,392	—	$0	31,415	SEC↗
Azan Alain	10% Owner	C Conversion	2013-02-05	2013-02-07	93,129	—	$0	2,072,914	SEC↗
Azan Alain	10% Owner	C Conversion	2013-02-05	2013-02-07	742	—	$0	43,767	SEC↗
Azan Alain	10% Owner	C Conversion	2013-02-05	2013-02-07	2,918	—	$0	30,023	SEC↗
Azan Alain	10% Owner	C Conversion	2013-02-05	2013-02-07	195,088	—	$0	1,979,785	SEC↗
Azan Alain	10% Owner	C Conversion	2013-02-05	2013-02-07	1,555	—	$0	43,025	SEC↗
Azan Alain	10% Owner	C Conversion	2013-02-05	2013-02-07	3,440	—	$0	27,105	SEC↗
Azan Alain	10% Owner	C Conversion	2013-02-05	2013-02-07	229,904	—	$0	1,784,697	SEC↗
Azan Alain	10% Owner	C Conversion	2013-02-05	2013-02-07	2,851	—	$0	8,452	SEC↗
Azan Alain	10% Owner	C Conversion	2013-02-05	2013-02-07	185,996	—	$0	560,201	SEC↗
Azan Alain	10% Owner	C Conversion	2013-02-05	2013-02-07	6,118	—	$0	9,291	SEC↗
Azan Alain	10% Owner	C Conversion	2013-02-05	2013-02-07	1,833	—	$0	41,470	SEC↗
Azan Alain	10% Owner	C Conversion	2013-02-05	2013-02-07	9,982	—	$0	23,665	SEC↗
DEVELOPMENT BANK OF JAPAN INC.	10% Owner	C Conversion	2013-02-05	2013-02-07	491,530	—	$0	491,530	SEC↗
BAXTER INTERNATIONAL INC	10% Owner	C Conversion	2013-02-05	2013-02-07	958,583	—	$0	958,583	SEC↗
Mitsubishi UFJ Capital II, Lim	10% Owner	C Conversion	2013-02-05	2013-02-07	393,223	—	$0	393,223	SEC↗
5AM Partners LLC	10% Owner	C Conversion	2013-02-05	2013-02-07	498,038	—	$0	721,228	SEC↗
Alloy Investors 2000, L.P.	10% Owner	C Conversion	2013-02-05	2013-02-07	1,683,817	—	$0	1,691,794	SEC↗
GBS Venture Partners Pty, Ltd	10% Owner	C Conversion	2013-02-05	2013-02-07	825,613	—	$0	850,613	SEC↗
Smith Brigitte	Director	C Conversion	2013-02-05	2013-02-07	825,613	—	$0	850,613	SEC↗
SOFINNOVA VENTURE AFFILIATES V	10% Owner	P Buy	2013-01-31	2013-02-04	366,592	$8.00	$2.93M	374,205	SEC↗
SOFINNOVA VENTURE AFFILIATES V	10% Owner	P Buy	2013-01-31	2013-02-04	2,923	$8.00	$23.4K	3,173	SEC↗
SOFINNOVA VENTURE AFFILIATES V	10% Owner	P Buy	2013-01-31	2013-02-04	5,485	$8.00	$43.9K	5,601	SEC↗
5AM VENTURES LLC	10% Owner	P Buy	2013-01-31	2013-02-04	62,500	$8.00	$500.0K	223,190	SEC↗
Smith Brigitte	Director	P Buy	2013-01-31	2013-02-04	25,000	$8.00	$200.0K	25,000	SEC↗
GBS Bioventures II A/C	10% Owner	P Buy	2013-01-31	2013-02-04	25,000	$8.00	$200.0K	25,000	SEC↗
Sanofi	Other	P Buy	2013-01-31	2013-02-07	87,500	$8.00	$700.0K	579,030	SEC↗